Agile Therapeutics Inc (AGRX)

Điều kiện giao dịch

Phiên giao dịch (UTC)
Thứ Hai: 11:00 - 00:00
Thứ Ba - Thứ Sáu: 00:00 - 00:30, 11:00 - 00:00
Thứ Bảy: 00:00 - 00:30

Nói về

Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. The Company is focused in the development and commercialization of prescription contraceptive products. The Company has developed a transdermal patch technology, called Skinfusion. The Company's lead product candidate is Twirla, also known as AG200-15, is a combined hormonal contraceptive (CHC) patch. In addition to Twirla, the Company is developing a pipeline of other new transdermal contraceptive products, including AG200-ER, which is a regimen designed to allow a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide a shortened hormone-free interval, and AG890, which is a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Each of its product candidates utilizes its Skinfusion technology designed to deliver contraceptive-levels of hormones to the blood stream through the skin over a seven-day period.

https://www.agiletherapeutics.com/